Stewart Fisher

Insider Reports History

Entity
Individual
Location
C4 Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, Massachusetts
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stewart Fisher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Scientific Officer Common Stock 129K $843K $6.53 Feb 14, 2024 Direct
C4 Therapeutics, Inc. Chief Scientific Officer Stock Option (Right to Buy) 118K Mar 7, 2024 Direct
C4 Therapeutics, Inc. Chief Scientific Officer Performance Restricted Stock Units 16.5K Aug 30, 2023 Direct

Insider Reports Filed by Stewart Fisher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CCCC C4 Therapeutics, Inc. Mar 7, 2024 4 $0 4 Mar 8, 2024 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Feb 13, 2024 3 -$14.7K 4 Feb 15, 2024 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Sep 18, 2023 1 $0 4 Sep 19, 2023 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Aug 30, 2023 3 -$1.94K 4 Aug 31, 2023 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Feb 13, 2023 2 $0 4 Feb 15, 2023 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Jan 30, 2023 3 -$10.1K 4 Feb 1, 2023 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. May 26, 2022 1 -$7.73K 4/A Jun 14, 2022 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. May 25, 2022 2 $0 4 May 27, 2022 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Apr 12, 2022 4 $137K 4 Apr 12, 2022 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Feb 14, 2022 2 $0 4 Feb 16, 2022 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Dec 8, 2021 6 $73K 4 Dec 10, 2021 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Aug 3, 2021 1 -$768K 4 Aug 5, 2021 Chief Scientific Officer
CCCC C4 Therapeutics, Inc. Jul 29, 2021 2 -$3.07M 4 Aug 2, 2021 Chief Scientific Officer